Bowtie and CUHK Hospital Unveil Innovative Medical Insurance + Health Package...
The oncology market in India is steadily growing, driven by an increasing cancer incidence and a strong demand for advanced treatments. However, there remains substantial untapped potential, primarily in improving access to cutting-edge therapies and expanding reach to underserved regions. Glenmark Pharma, with its patient-centric approach and innovative solutions, has been steadily increasing its market share by introducing high-quality and affordable cancer drugs. Alok Malik, President & ...
GALI™ SonR® CRT-D and NAVIGO™ 4LV Pacing Leads Launch Set to Enhance Heart Failure Management and Patient Safety...
Transforming the Lives of 1 Lakh Preterm Infants in India through Innovative Healthcare Solutions...
Care is becoming more personalized. Innovation cycles are growing shorter and shorter. Healthcare companies are increasingly looking for ways to eliminate waste and complexity. These are only a few of the reasons why 3D printing has become such an invaluable tool for MedTech research and design teams. 3D printing can make the impractical a reality. It can help providers customize devices to meet the unique care needs of individual patients almost immediately. It’s now even possible to 3D print m...
The National University of Singapore's Mechanobiology Institute (MBI) has recently secured a substantial S$49 million funding boost from the National Research Foundation (NRF) to propel advancements in mechanobiology. This funding, spread over seven years starting from December 2023, will be instrumental in conducting research to address age-related loss of biomechanical functions, particularly focusing on ailments such as infertility, chronic inflammatory diseases, muscle atrophy, and cancer....
Collaboration with Kenya Ministry of Health National Cancer Institute Aims to Expand Access to Diagnostics, Reduce Cervical Cancer Rates...
The world is finally paying attention to the impact of climate change on neglected diseases. What we need now is medical innovation....
Established in 2000, South Korea based Seegene Inc is a leader in molecular diagnostics and achieved remarkable financial success with over $1 billion in revenue and 65 per cent gross margins. With a mission for a disease-free world and proactive pandemic prevention, Seegene seamlessly integrates high multiplex diagnostic assays with automated testing systems. In an interaction with BioSpectrum & MedTech Spectrum, Dr Seong-Youl Kim, Seegene's Senior Vice President, shares insights on the company...
Since the launch of the global strategy against cervical cancer in 2020, the World Health Organization (WHO) has accelerated the initiative by virtue of commitments and strategies offered by governments and organisations worldwide. Australia is on track to become one of the first nations to achieve this, and countries like Bangladesh and Indonesia have introduced HPV vaccines. Let's examine Asia's efforts in eliminating cervical cancer and whether the continent is on track to meet WHO’s targets ...
